Deneysel Nöropatik Ağrı Modelleri
Özet
Nöropatik ağrı, somatosensoriyel sinir sisteminin hasar görmesi veya işlev bozukluğundan kaynaklanan bir kronik ağrı durumudur. Kronik ağrının küresel nüfusun %20'si kadarını etkilediği bilinirken, %10'u kadarının da nöropatik ağrı yaşadığı belirtilmiştir. Mevcut tedavi stratejileri genellikle temel nedenleri ele almak yerine yalnızca semptomatik rahatlama sunmaktadır. Nöropatik ağrının karmaşık mekanizmaları ve mevcut tedavilerin sınırlı etkinliği nedeniyle, altta yatan patofizyolojiyi çözmek ve yeni tedavi stratejileri geliştirmek için sağlam deneysel modeller çok önemlidir. Başlıca kemirgenlerde olmak üzere çeşitli deneysel modellerin geliştirilmesi, periferik sinir yaralanmalarından merkezi sinir sistemi lezyonlarına ve hatta metabolik veya kemoterapi kaynaklı nöropatilere kadar uzanan nöropatik ağrının nörobiyolojik temellerinin incelenmesinde kritik öneme sahiptir. Bu modellerin nöroinflamasyon, anormal plastisite ve değişmiş iyon kanalı işlevi dahil olmak üzere nöropatik ağrıya katkıda bulunan hücresel ve moleküler mekanizmaların açıklığa kavuşturulmasında yararlı oldukları ortaya koyulmaktadır. Bu bölümde, nöropatik ağrının etiyoloji, epidemiyoloji ve patofizyolojisi açıklanarak, deneysel hayvan modelleri üzerinde durulmuştur. Nöropatik ağrının deneysel modellerinin birbirine göre üstünlükleri, dezavantajları açıklanarak uygulama aşamaları belirtilmiştir. Böylece araştırmacılara, çalışmak istedikleri konuya göre en uygun deneysel model seçimi ve yorumlaması konusunda yol gösterici bir çerçeve sunulmaktadır.
Neuropathic pain is a chronic pain condition resulting from damage or dysfunction of the somatosensory nervous system. While chronic pain is known to affect up to 20% of the global population, it is estimated that approximately 10% experience neuropathic pain. Current treatment strategies often offer only symptomatic relief rather than addressing the underlying causes. Due to the complex mechanisms of neuropathic pain and the limited efficacy of current treatments, robust experimental models are crucial for elucidating the underlying pathophysiology and developing novel treatment strategies. The development of various experimental models, primarily in rodents, is critical in investigating the neurobiological basis of neuropathic pain, ranging from peripheral nerve injuries to central nervous system lesions and even metabolic or chemotherapy-induced neuropathies. These models are proving useful in elucidating the cellular and molecular mechanisms contributing to neuropathic pain, including neuroinflammation, abnormal plasticity, and altered ion channel function. This section describes the etiology, epidemiology, and pathophysiology of neuropathic pain, focusing on experimental animal models. The advantages and disadvantages of these experimental models are explained, along with their application stages. This provides researchers with a framework to guide them in selecting and interpreting the most appropriate experimental model for their research topic.
Referanslar
Rugnath R, Orzechowicz C, Newell C, et al. A Literature Review: The Mechanisms and Treatment of Neuropathic Pain—A Brief Discussion. Biomedicines. 2024;12(1):204.
Dehghan B, Abolhasanzadeh N, Shademan B, et al. Deciphering pain: molecular mechanisms and neurochemical pathways-challenges and future opportunities. Front Mol Biosci. 2024;11:1382555.
Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain. Neurology. 2008;70(18):1630-5.
Yalcin I, Megat S, Barthas F, et al. The sciatic nerve cuffing model of neuropathic pain in mice. J Vis Exp. 2014;(89):51608.
Colleoni M, Sacerdote P. Murine models of human neuropathic pain. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2010;1802(10):924-33.
Campbell JN, Meyer RA. Mechanisms of Neuropathic Pain. Neuron. 2006;52(1):77-92.
Bouhassira D. Neuropathic pain: Definition, assessment and epidemiology. Rev Neurol (Paris). 2019;175(1-2):16-25.
Scholz J, Finnerup NB, Attal N, et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 2019;160(1):53-9.
Zheng Q, Dong X, Green DP, et al. Peripheral mechanisms of chronic pain. Med Rev (2021). 2022;2(3):251-70.
Rekatsina M, Paladini A, Piroli A, et al. Pathophysiologic Approach to Pain Therapy for Complex Pain Entities: A Narrative Review. Pain Ther. 2020;9(1):7-21.
Mayoral V, Galvez R, Ferrándiz M, et al. Pregabalin vs. gabapentin in the treatment of neuropathic pain: a comprehensive systematic review and meta-analysis of effectiveness and safety. Front Pain Res (Lausanne). 2024;5:1513597.
Zachariou V, Carr F. Nociception and pain: lessons from optogenetics. Front Behav Neurosci [Internet]. (07 Kasım 2025 tarihinde https://www.frontiersin.org/journals/behavioral-neuroscience/articles/10.3389/fnbeh.2014.00069/full adresinden ulaşılmıştır).
Raja SN, Ringkamp M, Guan Y, et al. John J. Bonica Award Lecture: Peripheral neuronal hyperexcitability: the “low-hanging” target for safe therapeutic strategies in neuropathic pain. Pain. 2020;161 Suppl 1(Suppl 1):S14-26.
Chen Y long, Feng X lan, Cheung CW, et al. Mode of action of astrocytes in pain: From the spinal cord to the brain. Progress in Neurobiology. 2022;219:102365.
Cao B, Xu Q, Shi Y, et al. Pathology of pain and its implications for therapeutic interventions. Signal Transduct Target Ther. 2024;9(1):155.
Thomas Cheng H. Spinal Cord Mechanisms of Chronic Pain and Clinical Implications. Curr Pain Headache Rep. 2010;14(3):213-20.
Ji RR, Donnelly CR, Nedergaard M. Astrocytes in chronic pain and itch. Nat Rev Neurosci. 2019;20(11):667-85.
V M. Chronic pain and local pain in usually painless conditions including neuroma may be due to compressive proximal neural lesion. Frontiers in pain research (Lausanne, Switzerland) [Internet]. 20 Şubat 2023 (09 /11/ 2025 tarihinde https://pubmed.ncbi.nlm.nih.gov/36890855/ adresinden ulaşılmıştır).
Latremoliere A, Woolf CJ. Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity. The Journal of Pain. 2009;10(9):895-926.
The neurobiology of central sensitization - Harte - 2018 - Journal of Applied Biobehavioral Research - Wiley Online Library [İnternet]. (07 /11/ 2025 tarihinde https://onlinelibrary.wiley.com/doi/10.1111/jabr.12137 adresinden ulaşılmıştır).
Jarvis MF, Boyce-Rustay JM. Neuropathic pain: models and mechanisms. Curr Pharm Des. 2009;15(15):1711-6.
Walters ET, Crook RJ, Neely GG, et al. Persistent nociceptor hyperactivity as a painful evolutionary adaptation. Trends Neurosci. 2023;46(3):211-27.
Sommer C, Leinders M, Üçeyler N. Inflammation in the pathophysiology of neuropathic pain. Pain. 2018;159(3):595-602.
Gangadharan V, Kuner R. Pain hypersensitivity mechanisms at a glance. Dis Model Mech. 2013;6(4):889-95.
Das V. An introduction to pain pathways and pain “targets”. Prog Mol Biol Transl Sci. 2015;131:1-30.
Preventing chronic pain following acute pain: Risk factors, preventive strategies, and their efficacy - McGreevy - 2011 - European Journal of Pain Supplements - Wiley Online Library [İnternet]. (07 /11/ 2025 tarihinde https://onlinelibrary.wiley.com/doi/full/10.1016/j.eujps.2011.08.013 adresinden ulaşılmıştır).
Baron R, Hans G, Dickenson AH. Peripheral input and its importance for central sensitization. Ann Neurol. 2013;74(5):630-6.
Cheng JK, Ji RR. Intracellular Signaling in Primary Sensory Neurons and Persistent Pain. Neurochem Res. 2008;33(10):1970-8.
Taylor BK. Spinal inhibitory neurotransmission in neuropathic pain. Current Science Inc. 2009;13(3):208-14.
Lu HJ, Gao YJ. Astrocytes in Chronic Pain: Cellular and Molecular Mechanisms. Neurosci Bull. 2023;39(3):425-39.
Chiang CY, Sessle BJ, Dostrovsky JO. Role of Astrocytes in Pain. Neurochem Res. 2012;37(11):2419-31.
Ren K. Emerging role of astroglia in pain hypersensitivity. Japanese Dental Science Review. 2010;46(1):86-92.
O’Callaghan JP, Miller DB. Spinal glia and chronic pain. Metabolism. 2010;59:S21-6.
Li T, Chen X, Zhang C, et al. An update on reactive astrocytes in chronic pain. J Neuroinflammation. 2019;16(1):140.
Gao YJ, Ji RR. Targeting Astrocyte Signaling for Chronic Pain. Neurotherapeutics. 2010;7(4):482-93.
Astrocyte-microglia interaction through C3/C3aR pathway modulates neuropathic pain in rats model of chronic constriction injury - Wanying Mou, Lulu Ma, Afang Zhu, Huan Cui, Yuguang Huang, 2022 [İnternet]. 07/11/2025 tarihinde https://journals.sagepub.com/doi/10.1177/17448069221140532 adresinden ulaşılmıştır).
Ji RR, Berta T, Nedergaard M. Glia and pain: is chronic pain a gliopathy? Pain. 2013;154 Suppl 1(0 1):S10-28.
Hansen RR, Malcangio M. Astrocytes—Multitaskers in chronic pain. European Journal of Pharmacology. 2013;716(1):120-8.
Rose CR, Felix L, Zeug A, et al. Astroglial Glutamate Signaling and Uptake in the Hippocampus. Front Mol Neurosci. 2017;10:451.
Hertz L, Zielke HR. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends in Neurosciences. 2004;27(12):735-43.
Austin PJ, Fiore NT. Supraspinal neuroimmune crosstalk in chronic pain states. Current Opinion in Physiology. 2019;11:7-15.
Chen G, Luo X, Qadri MY, et al. Sex-Dependent Glial Signaling in Pathological Pain: Distinct Roles of Spinal Microglia and Astrocytes. Neurosci Bull. 2018;34(1):98-108.
Cheng Z, Feng S, Yang L, et al. Rat Model of Neuropathic Pain Induced by Spinal Nerve Ligation: A New Approach via an Oblique Lateral Incision. JPR. 2024;17:2443-54.
Jaggi AS, Jain V, Singh N. Animal models of neuropathic pain. Fundam Clin Pharmacol. 2011;25(1):1-28.
Bouali-Benazzouz R, Landry M, Benazzouz A, et al. Neuropathic pain modeling: Focus on synaptic and ion channel mechanisms. Prog Neurobiol. 2021;201:102030.
Gregory NS, Harris AL, Robinson CR, et al. An Overview of Animal Models of Pain: Disease Models and Outcome Measures. The Journal of Pain. 2013;14(11):1255-69.
McGonigle P, Ruggeri B. Animal models of human disease: Challenges in enabling translation. Biochemical Pharmacology. 2014;87(1):162-71.
Sant’Anna MB, Kusuda R, Bozzo TA, et al. Medial plantar nerve ligation as a novel model of neuropathic pain in mice: pharmacological and molecular characterization. Sci Rep. 2016;6:26955.
Kaplan B, Levenberg S. The Role of Biomaterials in Peripheral Nerve and Spinal Cord Injury: A Review. Int J Mol Sci. 2022;23(3):1244.
Arthur-Farraj P, Coleman MP. Lessons from Injury: How Nerve Injury Studies Reveal Basic Biological Mechanisms and Therapeutic Opportunities for Peripheral Nerve Diseases. Neurotherapeutics. 2021;18(4):2200-21.
Sprenger-Svačina A, Svačina MKR, Otlu HG, et al. Endoneurial immune interplay in peripheral nerve repair: insights and implications for future therapeutic interventions. Front Neurosci [Internet]. (07/11/2025 tarihinde https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2025.1602112/full adresinden ulaşılmıştır).
Angius D, Wang H, Spinner RJ, et al. A systematic review of animal models used to study nerve regeneration in tissue-engineered scaffolds. Biomaterials. 2012;33(32):8034-9.
Al-Majed AA, Neumann CM, Brushart TM, et al. Brief electrical stimulation promotes the speed and accuracy of motor axonal regeneration. J Neurosci. 2000;20(7):2602-8.
Liao W, Shi Y, Li Z, et al. Advances in 3D printing combined with tissue engineering for nerve regeneration and repair. Journal of Nanobiotechnology. 2025;23(1):5.
Wang L, Wu Y, Hu T, et al. Aligned conductive core-shell biomimetic scaffolds based on nanofiber yarns/hydrogel for enhanced 3D neurite outgrowth alignment and elongation. Acta Biomaterialia. 2019;96:175-87.
Tung TH. Clinical strategies to enhance nerve regeneration. Neural Regen Res. 2015;10(1):22-4.
Pathak NN, Balaganur V, Lingaraju MC, et al. Antihyperalgesic and anti-inflammatory effects of atorvastatin in chronic constriction injury-induced neuropathic pain in rats. Inflammation. 2013;36(6):1468-78.
Shi JY, Liu GS, Liu LF, et al. Glial cell line-derived neurotrophic factor gene transfer exerts protective effect on axons in sciatic nerve following constriction-induced peripheral nerve injury. Hum Gene Ther. 2011;22(6):721-31.
Yaksh TL. Spinal systems and pain processing: development of novel analgesic drugs with mechanistically defined models. Trends Pharmacol Sci. 1999;20(8):329-37.
Muschler GF, Raut VP, Patterson TE, et al. The design and use of animal models for translational research in bone tissue engineering and regenerative medicine. Tissue Eng Part B Rev. 2010;16(1):123-45.
Mao J. Translational Pain Research: Achievements and Challenges. The Journal of Pain. 2009;10(10):1001-11.
Tissue-engineered disease models. Nat Biomed Eng. 2018;2(12):879-80.
Silva-Reis R, Faustino-Rocha AI, Silva J, et al. Studying and Analyzing Humane Endpoints in the Fructose-Fed and Streptozotocin-Injected Rat Model of Diabetes. Animals. 2023;13(8):1397.
Animal models of bone metastasis - Rosol - 2003 - Cancer - Wiley Online Library [İnternet]. (07 /11/ 2025 tarihinde). https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.11150
Drug Discovery and Development - Present and Future | IntechOpen [İnternet]. ( 09/11/2025). https://www.intechopen.com/books/671
Ivanova N, Hristov M, Gateva P. Rodent Models of Diabetic Neuropathy, Role of Calcium Homeostasis in Pain and KB-R7943 as a Potential Therapeutic. International Journal of Molecular Sciences. 2025;26(5):2094.
Hincker A, Frey K, Rao L, et al. Somatosensory predictors of response to pregabalin in painful chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled, crossover study. Pain. 2019;160(8):1835-46.
Cavaletti G, Marmiroli P, Renn CL, et al. Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity? Neurotherapeutics. 2021;18(4):2324-36.
Yoon SY, Oh J. Neuropathic cancer pain: prevalence, pathophysiology, and management. Korean J Intern Med. 2018;33(6):1058-69.
Atreya S. Pregabalin in Chemotherapy Induced Neuropathic Pain. Indian J Palliat Care. 2016;22(1):101-3.
Strong CE, Zhang J, Carrasco M, et al. Functional brain region-specific neural spheroids for modeling neurological diseases and therapeutics screening. Commun Biol. 2023;6(1):1211.
Loewa A, Feng JJ, Hedtrich S. Human disease models in drug development. Nat Rev Bioeng. 2023;1(8):545-59.
Lee SO, Kuthati Y, Huang WH, et al. Semaglutide Ameliorates Diabetic Neuropathic Pain by Inhibiting Neuroinflammation in the Spinal Cord. Cells. 2024;13(22):1857.
Do JG, Noh SU, Chae SW, et al. Excessive walking exercise precipitates diabetic neuropathic foot pain: hind paw suspension treadmill exercise experiment in a rat model. Sci Rep. 2020;10(1):10498.
Attrill EH, Scharapow O, Perera S, et al. Controlled induction of type 2 diabetes in mice using high fat diet and osmotic-mini pump infused streptozotocin. Sci Rep. 2025;15(1):8812.
Xu X hong, Zhong Z. Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells. Acta Pharmacol Sin. 2013;34(6):755-64.
Mohamed NV, Larroquette F, Beitel LK, et al. One Step Into the Future: New iPSC Tools to Advance Research in Parkinson’s Disease and Neurological Disorders. J Parkinsons Dis. 2019;9(2):265-81.
Zhao X, Bhattacharyya A. Human Models Are Needed for Studying Human Neurodevelopmental Disorders. Am J Hum Genet. 2018;103(6):829-57.
Devine MJ, Ryten M, Vodicka P, et al. Parkinson’s disease induced pluripotent stem cells with triplication of the α-synuclein locus. Nat Commun. 2011;2:440.
Amartumur S, Nguyen H, Huynh T, et al. Neuropathogenesis-on-chips for neurodegenerative diseases. Nat Commun. 2024;15(1):2219.
Abd Razak NH, Idris J, Hassan NH, et al. Unveiling the Role of Schwann Cell Plasticity in the Pathogenesis of Diabetic Peripheral Neuropathy. International Journal of Molecular Sciences. 2024;25(19):10785.
Zhang DW, Fu M, Gao SH, et al. Curcumin and diabetes: a systematic review. Evid Based Complement Alternat Med. 2013;2013:636053.
Evans MC, Wade C, Hohenschurz-Schmidt D, et al. Magnetic Resonance Imaging as a Biomarker in Diabetic and HIV-Associated Peripheral Neuropathy: A Systematic Review-Based Narrative. Front Neurosci. 2021;15:727311.
